In Vivo Pharmacokinetic Studies of Albendazole Nanoparticulate Oral Formulations for Improved Bioavailability

REFERENCES

• Cook , G. C. 1990 . Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy . Parasitol. Today , 6 : 133 – 136 .
   Google Scholar
• Wen , H. , New , R. R. C. and Craig , P. S. 1993 . Diagnosis and treatment of human hydatidosis . Br. J. Clin. Pharm. , 35 : 565 – 574 .
   Google Scholar
• WHO Informal Working Group on Echinococcosis . 1996 . Guidelines for treatment of cystic alveolar echinococcosis in humans . Bull. WHO , 74 : 231 – 242 .
   Google Scholar
• Misra , P. K. , Kumar , A. , Agarwal , U. and Jagota , S. C. 1995 . A comparative clinical trial of albendazole vs metronidazole in giardiasis . Indian Pediatr. , 32 : 291 – 294 .
   Google Scholar
• Lecuit , N. , Oksenhendler , E. and Sarfati , C. 1994 . The use of albendazole for disseminated microsporidian infection in patients with AIDS . Clin. Infect. Dis. , 19 : 332 – 333 .
   Google Scholar
• Lopez-Garcia , M. L. , Torrado-Duran , S. , Torrado-Duran , J. , Martinez , A. R. and Bolas , F. 1997 . Albendazole versus ricobendazole against enteral and parenteral stages of Trichinella spiralis in mice . Int. J. Parasitol. , 27 : 781 – 785 .
   Google Scholar
• Keramidas , D. , Mavridis , G. , Soutis , M. and Passalidis , A. 2004 . Medical treatment of pulmonary hydatidosis: complications and surgical management . Pediatr. Surg. Int. , 19 : 774 – 776 .
   Google Scholar
• Del-Brutto , O. H. , Sotelo , I. and Raman , G. C. 1993 . Therapy for neurocysticercosis: a reappraisal . Clin. Infect. Dis. , 17 : 730 – 733 .
   Google Scholar
• Gil-Grande , L. A. , Rodriguez-Caabeiro , F. , Prieto , J. G. , Sánchez-Ruano , J. J. and Brasa , C. 1993 . Randomised controlled trial of efficacy of Albendazole in intra-abdominal hydatid disease . Lancet , 342 : 1269 – 1272 .
   Google Scholar
• Van–Nieuwkerk , K. M. J. , Veenstra , J. , Wassenaar , R. P. , Blaauwgeers , H. L. , Geraedts , A. A. and Kroes , H. 1993 . Pancreatitis causes by rupture of liver hydatid cyst . Eur. J. Gastroenterol. Hepatol. , 5 : 563 – 565 .
   Google Scholar
• Yasawy , M. I. , ALKarawi , M. A. and Are , M. 1993 . Combination of praziquantel and albendazole in the treatment of hydatid disease . Trop. Med. Parasitol. , 44 : 192 – 195 .
   Google Scholar
• Amidon , G. L. , Lennernas , H. , Shah , V. P. and Crison , J. R. 1995 . A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability . Pharm. Res. , 12 : 413 – 420 .
   Google Scholar
• Jung , H. , Medina , L. , Garcia , L. , Fuentes , I. and Esparza , R. M. 1998 . Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite, albendazole sulphoxide . J. Pharm. Pharmacol. , 50 : 43 – 48 .
   Google Scholar
• Torrado , S. S. , Lopez , M. L. , Torrado , G. , Bolas , G. , Torrado , S. and Cadorniga , R. 1997 . A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation . Int. J. Pharm. , 156 : 181 – 187 .
   Google Scholar
• Torrado , S. , Torrado , S. , Torrado , J. J. and Cadorniga , R. 1996 . Preparation, dissolution and characterization of albendazole solid dispersions . Int. J. Pharm. , 140 : 247 – 250 .
   Google Scholar
• Jacobs , C. , Kayser , O. and Muller , R. H. 2000 . Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide . Int. J. Pharm. , 196 : 161 – 164 .
   Google Scholar
• Kayser , O. , Olbrich , C. , Yardley , V. , Kiderlen , A. F. and Croft , S. L. 2003 . Formulation of amphotericin B as nanosuspension for oral administration . Int. J. Pharm. , 254 : 73 – 75 .
   Google Scholar
• Ravichandran , R. 2009 . Nanoparticles in drug delivery: potential green nanobiomedicine applications . Int. J. Green Nanotechnol. Biomed. , 1 : B108 – B130 .
   Google Scholar
• Ravichandran , R. 2009 . Nanotechnology-based drug delivery systems . NanoBiotechnology , 5 ( 1 ) : 17 – 33 .
   Google Scholar
• Chen , X. , Young , T. J. , Sarkari , M. , Williams , R. O. and Johnston , K. P. 2002 . Preparation of cyclosporine: a nanoparticles by evaporative precipitation into aqueous solution . Int. J. Pharm. , 242 : 3 – 14 .
   Google Scholar
• Muller , R. H. , Jacobs , C. and Kayser , O. 2001 . Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future . Ad. Drug Del. Rev. , 47 : 3 – 19 .
   Google Scholar
• Weder , H. G. and van Hoogevest , P. Nanosuspensions for intravenous administration . US 5726164 . 1998 .
   Google Scholar
• Muller , R. H. and Jacobs , C. 2002 . Buparvaquone mucoadhesive nanosuspensions: Preparation, optimisation and long-term stability . Int. J. Pharm. , 237 : 151 – 161 .
   Google Scholar
• Rabinow , B. E. 2004 . Nanosuspensions in drug delivery . Nat. Rev. Drug. Discov. , 3 : 785 – 96 .
   Google Scholar
• Keck , C. M. and Muller , R. H. 2006 . Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization . Eur. J. Pharm. Biopharm. , 62 : 3 – 16 .
   Google Scholar
• Liversidge , G. G. and Cundy , K. C. 1995 . Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs . Int. J. Pharm. , 125 : 91 – 97 .
   Google Scholar
• Jinno , J. , Naoki , K. , Miyake , M. , Yamada , K. , Mukia , T. , Odomi , M. , Togu-chi , H. , Liversidge , G. G. , Higaki , K. and Kimura , T. 2006 . Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs . J. Control. Release , 111 : 56 – 64 .
   Google Scholar
• Liversidge , G. G. and Conzentino , P. 1995 . Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats . Int. J. Pharm. , 125 : 309 – 313 .
   Google Scholar
• Rao , Y. M. , Kumar , M. P. and Apte , S. 2008 . Formulation of nanosuspensions of albendazole for oral administration . Curr. Nanosci. , 4 : 53 – 58 .
   Google Scholar
• Pavan Kumar , M. , Madhusudan Rao , Y. and Apte , S. 2007 . Improved bioavailability of albendazole following oral administration of nanosuspension in rats . Curr. Nanosci. , 3 : 191 – 194 .
   Google Scholar
• Davis , A. , Dixon , H. and Pawlowski , Z. S. 1989 . Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2) . Bull. W. H. O. , 67 : 503 – 508 .
   Google Scholar
• Horton , R. J. 1997 . Albendazole in treatment of human cystic echinococcosis: 12 years of experience . Acta Trop. , 64 : 79 – 93 .
   Google Scholar
• Jung , H. , Medina , L. , Garcia , L. , Fuentes , I. and Moreno-Esparza , R. 1998 . Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide . J. Pharm. Pharmacol. , 50 : 43 – 48 .
   Google Scholar
• Kohri , N. , Yamayoshi , Y. , Xin , H. , Iseki , K. , Sato , N. , Todo , S. and Miyazaki , K. 1999 . Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique . J. Pharm. Pharmacol. , 51 : 159 – 164 .
   Google Scholar
• del Estal , J. L. , Alvarez , A. I. , Villaverde , C. , Coronel , P. , Fabra , S. and Prieto , J. G. 1991 . Effect of surfactants on albendazole absorption . J. Pharm. Biomed. Anal. , 9 : 1161 – 1164 .
   Google Scholar
• del Estal , J. L. , Alvarez , A. I. , Villaverde , C. , Justel , A. and Prieto , J. G. 1994 . Increased systemic bioavailability of albendazol when administered with surfactants in rats . Int. J. Pharm. , 102 : 257 – 260 .
   Google Scholar
• del Estal , J. L. , Alvarez , A. I. , Villaverde , C. and Prieto , J. G. 1993 . Comparative effects of anionic, natural bile acid surfactants and mixed micelles on the intestinal absorption of the anthelmintic albendazole . Int. J. Pharm. , 91 : 105 – 109 .
   Google Scholar
• Wen , H. , New , R. R. C. , Muhmut , M. , Wang , J. H. , Wang , Y. H. , Zhang , J. H. , Shao , Y. M. and Craig , P. S. 1996 . Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine . Parasitology , 13 : 111 – 121 .
   Google Scholar
• Evrard , B. , Chiap , P. , DeTullio , P. , Ghalmi , F. , Piel , G. , van Hees , T. , Crommen , J. , Losson , B. and DaLattre , L. 2002 . Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin . J. Control. Release , 85 : 45 – 50 .
   Google Scholar
• Piel , G. , Evrard , B. , Van Hees , T. , Llabres , G. and Delattre , L. 1999 . Development of a parenteral and of an oral formulation of albendazole with cyclodextrins . Stp. Pharma. Sci. , 9 : 257 – 260 .
   Google Scholar
• Awadzi , K. , Hero , M. , Opoku , N. O. , Büttner , D. W. , Coventry , P. A. , Prime , M. A. , Orme , M. L. E. and Edwards , G. 1994 . The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics . Trop. Med. Parasitol. , 45 : 203 – 208 .
   Google Scholar
• Homeida , M. , Leahy , W. , Copeland , S. , Ali , M. M. and Harron , D. W. 1994 . Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men . Ann. Trop. Med. Parasitol. , 88 : 551 – 559 .
   Google Scholar
• Lange , H. , Eggers , R. and Bircher , J. 1988 . Increased systemic availability of albendazole when taken with a fatty meal . Eur. J. Clin. Pharmacol. , 34 : 315 – 317 .
   Google Scholar
• Nagy , J. , Schipper , H. G. , Koopmans , R. P. , Butter , J. J. , van Boxtel , C. J. and Kager , P. A. 2002 . Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability . Am. J. Trop. Med. Hyg. , 66 : 260 – 263 .
   Google Scholar
• Schipper , H. G. , Koopmans , R. P. , Nagy , J. , Butter , J. J. , Kager , P. A. and van Boxtel , C. J. 2000 . Effect of dose increase or cimetidine co-administration on albendazole bioavailability . Am. J. Trop. Med. Hyg. , 63 : 270 – 273 .
   Google Scholar
• Mingjie , W. , Shuhua , X. , Junjie , C. , Bin , L. , Cheng , F. , Weixia , S. and Hotez , P. 2002 . Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence . Acta Trop. , 83 : 177 – 181 .
   Google Scholar
• McKellar , Q. A. and Scott , E. W. 1990 . The benzimidazole anthelmintic agent: a review . J. Vet. Pharmacol. Ther. , 13 : 223 – 247 .
   Google Scholar
• Delatour , P. , Benoit , E. and Besse , S. 1991 . Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats . Xenobiotica , 21 : 217 – 221 .
   Google Scholar
• Lopez-Garcia , M. L. , Torrado , S. , Torrado , S. , Martinez , A. R. and Bolas , F. 1998 . Methimazole-mediated enhancement of albendazole bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime . Vet. Parasitol. , 75 : 209 – 219 .
   Google Scholar
• Gyurik , R. J. , Chow , A. W. , Zaber , B. , Bruner , E. L. , Miller , J. A. , Villani , A. J. , Petka , L. A. and Parish , R. C. 1981 . Metabolism of albendazole in cattle, sheep, rats and mice . Drug Metab. Dispos. , 9 : 503 – 08 .
   Google Scholar
• Pedersen , M. 1997 . The bioavailability difference between genuine cyclodextrin inclusion complexes and freeze-dried or ground drug-cyclodextrin samples may be due to supersaturation differences . Drug Dev. Ind. Pharm. , 23 : 331 – 335 .
   Google Scholar
• Liversidge , G. G. and Conzentino , P. 1995 . Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats . Int. J. Pharm. , 125 : 309 – 313 .
   Google Scholar
• Adams , M. L. , Lavasanifar , A. and Kwon , G. S. 2003 . Amphiphilic block copolymers for drug delivery . J. Pharm. Sci. , 92 : 1343 – 1355 .
   Google Scholar
• Rigter , I. M. , Schipper , H. G. , Koopmans van Kan , R. P. , Frijlink , H. J. M. , Kager , H. W. and Guchelaar , P. A. H.-J. 2004 . Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers . Antimicrob. Agents Chemother. , 48 : 1051 – 1054 .
   Google Scholar
• García , J. J. , Francisco Bolása , F. and Torrado , J. J. 2003 . Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole . Int. J. Pharmaceut. , 250 : 351 – 358 .
   Google Scholar
• Garcia , J. J. , Bolás-Fernándeza , F. and Torrado , J. J. 1999 . Quantitative determination of albendazole and its main metabolites in plasma . J. Chromatogr. B Biomed. Sci. Appl. , 723 : 265 – 271 .
   Google Scholar
• Torrado , S. , Torrado , S. , Cadorniga , R. and Torrado , J. J. 1996 . Formulation parameters of albendazole solution . Int. J. Pharm. , 140 : 45 – 50 .
   Google Scholar